Raindrop Near Vision Inlay withdrawn from use following health warnings
Surgical eye implant could cause blurred vision, warn health authorities
Warnings have been issued by government health officials against the use of an unregulated medical device promising to improve eyesight.
The Ministry of Health and Prevention (Mohap) has followed the lead of the US Food and Drug Administration to advise caution against the use of Raindrop Near Vision Inlay — a medical device produced by Optics Medical Company.
Also known as the RVO 2.0 device, it is surgically implanted in the eyes to improve vision as an alternative to glasses and contact lenses.
“The FDA warning says people who undergo this procedure are at risk of developing cornea hypertrophy, which can affect clear eyesight and cause blurred vision,” said Dr Ruqaya Al Bastaki, head of the Mohap drug department.
“We recommend all healthcare professionals take this action and avoid performing the procedure.
“Doctors should contact the manufacturer to return unused products and monitor patients who have been implanted with the device and provide them with the necessary treatments.”
Similar guidance has been issued against the use of hypertension medicines Lobet in 100mg and Ampoule in 20mg.
Both are drugs produced by Samarath Life Sciences Pvt. Ltd and have been withdrawn by the Gulf Health Council.
The warning is based on a circular earlier released by the Saudi Food and Drug Authority that raised quality concerns in the product caused by the presence of impurities found inside samples.
Anyone suffering side effects from either of these products should contact the ministry by calling 02 301 448 04 or email email@example.com.